216 related articles for article (PubMed ID: 16248281)
1. Gene therapy in the treatment of Fanconi anemia, a progressive bone marrow failure syndrome.
Williams DA; Croop J; Kelly P
Curr Opin Mol Ther; 2005 Oct; 7(5):461-6. PubMed ID: 16248281
[TBL] [Abstract][Full Text] [Related]
2. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for fanconi anemia.
Croop JM
Curr Hematol Rep; 2003 Jul; 2(4):335-40. PubMed ID: 12901331
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer for the eventual treatment of Fanconi's anemia.
Liu JM
Semin Hematol; 1998 Apr; 35(2):168-79. PubMed ID: 9565158
[TBL] [Abstract][Full Text] [Related]
5. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C.
Noll M; Bateman RL; D'Andrea AD; Grompe M
Mol Ther; 2001 Jan; 3(1):14-23. PubMed ID: 11162306
[TBL] [Abstract][Full Text] [Related]
6. In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients.
Cohen-Haguenauer O; Péault B; Bauche C; Daniel MT; Casal I; Levy V; Dausset J; Boiron M; Auclair C; Gluckman E; Marty M
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2340-5. PubMed ID: 16461901
[TBL] [Abstract][Full Text] [Related]
7. Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia.
González-Murillo A; Lozano ML; Alvarez L; Jacome A; Almarza E; Navarro S; Segovia JC; Hanenberg H; Guenechea G; Bueren JA; Río P
Hum Gene Ther; 2010 May; 21(5):623-30. PubMed ID: 20001454
[TBL] [Abstract][Full Text] [Related]
8. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
[TBL] [Abstract][Full Text] [Related]
9. Fanconi anemia and beta c deficiency-associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by stem cell gene therapy but require different therapeutic approaches.
Dirksen U; Moritz T; Burdach S; Flasshove M; Hanenberg H
Klin Padiatr; 1999; 211(4):329-35. PubMed ID: 10472572
[TBL] [Abstract][Full Text] [Related]
10. Progress towards hematopoietic stem cell gene therapy.
Kurre P; Kiem HP
Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1.
Navarro S; Meza NW; Quintana-Bustamante O; Casado JA; Jacome A; McAllister K; Puerto S; Surrallés J; Segovia JC; Bueren JA
Mol Ther; 2006 Oct; 14(4):525-35. PubMed ID: 16859999
[TBL] [Abstract][Full Text] [Related]
12. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
Hanenberg H; Roellecke K; Wiek C
Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
[TBL] [Abstract][Full Text] [Related]
13. Fanconi anaemia: new strategies.
Dufour C; Svahn J
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S90-5. PubMed ID: 18545254
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.
Chakkaramakkil Verghese S; Goloviznina NA; Kurre P
Stem Cell Res Ther; 2016 Nov; 7(1):170. PubMed ID: 27865213
[TBL] [Abstract][Full Text] [Related]
15. Advances in Gene Therapy for Fanconi Anemia.
Río P; Navarro S; Bueren JA
Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
[TBL] [Abstract][Full Text] [Related]
16. HSCT for Fanconi anemia in children: factors that influence early and late results.
Dalle JH
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S51-3. PubMed ID: 18978745
[TBL] [Abstract][Full Text] [Related]
17. A novel, membrane receptor-based retroviral vector for Fanconi anemia group C gene therapy.
Machl AW; Planitzer S; Kubbies M
Gene Ther; 1997 Apr; 4(4):339-45. PubMed ID: 9176520
[TBL] [Abstract][Full Text] [Related]
18. The clinical and biological overlap between Nijmegen Breakage Syndrome and Fanconi anemia.
Gennery AR; Slatter MA; Bhattacharya A; Barge D; Haigh S; O'Driscoll M; Coleman R; Abinun M; Flood TJ; Cant AJ; Jeggo PA
Clin Immunol; 2004 Nov; 113(2):214-9. PubMed ID: 15451479
[TBL] [Abstract][Full Text] [Related]
19. Lessons Learned from Two Decades of Clinical Trial Experience in Gene Therapy for Fanconi Anemia.
Adair JE; Sevilla J; Heredia CD; Becker PS; Kiem HP; Bueren J
Curr Gene Ther; 2017; 16(5):338-348. PubMed ID: 28103787
[TBL] [Abstract][Full Text] [Related]
20. Current clinical management of Fanconi anemia.
Smith AR; Wagner JE
Expert Rev Hematol; 2012 Oct; 5(5):513-22. PubMed ID: 23146055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
